BTX

BlackRock Technology and Privat

$8.55

-$0.33 (-3.63%)Today

-$0.20 (-2.29%)Pre-Market

Key Statistics

Market cap1.02B

Price-Earnings ratio23.65

Dividend yield—

Average volume672.06K

High today$8.87

Low today$8.73

Open price$8.95

Volume602.97K

52 Week high$9.44

52 Week low$6.13

Company Profile

Description

BlackRock Technology and Private Equity Term Trust is a mutual fund launched by BlackRock, Inc. The fund is managed by BlackRock Advisors, LLC. BlackRock Technology and Private Equity Term Trust is domiciled in the United States.

Sector

Financial Services

Industry

Asset Management

Company Profile

Description

Sector

Financial Services

Industry

Asset Management

BTX

Key Statistics

Company Profile

Company Profile

Recent News

Age-related Macular Degeneration Clinical Trial Pipeline: DelveInsight Highlights Major Advances, Transformative Therapies, and 90+ Leading Players Wheeling the Therapeutics Landscape

Australian Investors Want Innovation, But Structural Barriers are Holding Them Back, New Report Finds

Distribution Dates and Amounts Announced for Certain BlackRock Closed-End Funds

$62Bn Vanished: Is the Bitcoin Corporate Treasury Meta Dead?

Certain BlackRock Closed-End Funds Announce Estimated Sources of Distributions

Hikal Ltd (BOM:524735) Q4 2026 Earnings Call Highlights: Operational Efficiency Gains Amidst ...

Biotheryx Announces Data from its Phase 1 Dose Escalation Study of BTX-9341, a First-in-Class, Potent and Selective CDK4/6 Degrader, for the Treatment of Advanced/Metastatic HR+/HER2- Breast Cancer

Harvard Bioscience Announces First Quarter 2026 Financial Results

Recent News

Recent News

Age-related Macular Degeneration Clinical Trial Pipeline: DelveInsight Highlights Major Advances, Transformative Therapies, and 90+ Leading Players Wheeling the Therapeutics Landscape

Australian Investors Want Innovation, But Structural Barriers are Holding Them Back, New Report Finds

Distribution Dates and Amounts Announced for Certain BlackRock Closed-End Funds

$62Bn Vanished: Is the Bitcoin Corporate Treasury Meta Dead?

Certain BlackRock Closed-End Funds Announce Estimated Sources of Distributions

Hikal Ltd (BOM:524735) Q4 2026 Earnings Call Highlights: Operational Efficiency Gains Amidst ...

Biotheryx Announces Data from its Phase 1 Dose Escalation Study of BTX-9341, a First-in-Class, Potent and Selective CDK4/6 Degrader, for the Treatment of Advanced/Metastatic HR+/HER2- Breast Cancer

Harvard Bioscience Announces First Quarter 2026 Financial Results

Company Profile